Collagen, the most abundant component of extracellular matrix, is a molecule of choice for the development of cellular biomaterials, because it can interact with most cell types and can facilitate their adhesion and growth. In this study, electrospun nanofibrous collagen patches was used to provide a biocompatible physical support for the graft of human pluripotent stem cells derived cardiomyocytes (hPCS-CM) for the treatment of the failing heart. Different types of clinically approved collagen were studied for their ability to form high quality uniform fibers by electrospinning using a benign solvent system based on ethanol, water and salts. Atelocollagen -that contains 95% of type I and 5% of type III -exhibited the best performance. After appropriate crosslinking using cytocompatible agents based on citric acid (concentrated to 5% or 10%), the collagen was placed to special holders for cell culture.
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The electrospun collagen patches were used for culture of newborn rats cardiomyocytes, showing regular beating after 3 days of culture. They already have been successfully used for the culture of hPSC-CM. Finally, the electrospun collagen patches have been implanted in mice with dilated cardiomyopathy and have exhibited excellent biocompatibility. Cardiac function measured by echocardiography before and after the graft, histological, and molecular studies showed no detrimental effects of the collagen scaffold. Our next target is the implantation of hPSC-CM-seeded scaffold in mice with dilated cardiomyopathy. The possibility to reboot the proliferation of adult resident cardiomyocytes (CMs) has emerged as a promising avenue in cardiac regenerative medicine. For that purpose, there is an urgent need for identifying the molecular mechanisms involved in the natural blockage of adult CMs proliferation. Recently, we recently demonstrated that ephrin-B1 expression in the CMs nuclei acts as a specific inhibitor of the adult CMs proliferation (unpublished data). Here, we have explored the specific role of the PI3Kγ in the nuclearization of ephrin-B1.
Fluorescent immunostaining showed a specific loss of nuclear ephrin-B1 in p110-γ KO but not in KI mice, suggesting a specific role of the PKAanchoring function of the p110-γ catalytic subunit of PI3Kγ in ephrin-B1 nuclearization. Interestingly, p110-γ KO mice demonstrated a significant increase of mononucleated CMs (19,1 ± 1,1 % vs 13,3 ± 1,0 % in WT) correlated to a decrease in binucleated CMs (70,9 ± 1,9 % vs 79,7 ±1,0 % in WT) possibly indicative of a proliferative potential. In agreement with a proliferative potential, we measured a higher level of replicative-BrdU+ CMs in KO PI3Kγ mice (WT: 6,23±2,2 % ; KO: 19,3±4,9 %; KI: 3,0±0,8 %), but also a higher CMs density in cardiac tissue from 8 month old mice (WT: 2633±79,4cm/mm²; KO: 3208±155,6CM/mm²; KI: 2659,7±99,3CM/mm²) mosy likely reflecting CMs hyperplasia. To confirm the involvement of a cAMP/PKA pathway in ephrin-B1 nuclearization, we studied a neonatal cardiomyoblast cell line (H9C2) naturally expressing a nuclear ephrin-B1 pool. We showed that H89 treatment prevented ephrin-B1 nuclearization while forskolin promoted nuclearization of a recombinant ephrin-B1-GFP.
These results demonstrated for the first time the specific role of the cAMP/ PKA/PI3Kγ pathway in ephrin-B1 nuclearization in the CM. In the future, the accurate characterization of this pathway could allow identifying new and more specific targets for heart regenerative medicine strategies. Human pluripotent stem cells derived cardiomyoctyes are one the most promising cells for cardiac research, i.e. disease modeling, drug screening and cell therapy applications. Obtaining these cells is a critical step and has been the subject of many studies and publications. Recent advances in this field have shown that a sequential activation and inhibition of the Wnt pathway induces the differentiation of human pluripotent stem cells toward the cardiac lineage. This procedure can be achieved in a chemically-defined environment, and beating cells are obtained after 8 days.
Several parameters of this protocol could still be improved. For example, the small molecules used (Wnt activators and inhibitors) are not approved by the health authorities, preventing their use in clinical studies. Moreover, there are no standard procedures to recover the cardiomyocytes after the differentiation protocol. Finally, late-stage differentiation to a totally matured ventricular cardiomyocyte population has not been achieved for the moment. The immature cardiac cells obtained have several differences compared to adult cardiomyocytes. There are, for example, mismatches in cell size and shape, gap junction, alignment and calcium handling ability. Raise these technological barriers could lead to new perspectives in the use of these cells.
Our studies in this area have led us to develop innovative strategies to obtain, recover and to mature these cells. We have tested several FDAapproved drugs known to modulate the Wnt pathway in order to obtain a clinical-grade population cardiomyocytes. We also determined, using a combination of protease, the condition of recovery allowing the best survival rate and function of these cells. Finally, we improve the maturity of cardiomyocytes derived from pluripotent stem cells by tuning their micro-environment. Our results demonstrate the importance of the extracellular matrix composition and mechanical properties. The possibility to reboot the proliferation of adult resident cardiomyocytes (CM) has recently emerged as a new promising avenue in cardiac regenerative medicine. For that purpose, there is an urgent need for identifying the molecular mechanisms involved in the natural blockage of adult CM proliferation.
We recently identified ephrin-B1 as specific stabilizer of the CM rod-shape allowing the cardiac tissue cohesion. Interestingly, we found that ephrin-B1 knock-out mice (KO) compensate aging stress through a surprising CM hyperplasia, suggesting an atypical proliferation of adult CM. Cell cycle genes profiling performed by qRT-PCR showed that old KO CM significantly upregulated genes involved in all cell cycle phases. Progression of CM throughout the cell cycle was confirmed by flow cytometry and revealed the presence of the replicative S-phase only in old KO CM. Proliferation was next 
